Circe Biomedical
Welcome to Circe Biomedical
United States · $28.0M raised
- Business Model
- B2B
- Website
- circebio.com
- Total Funding
- $28.0M
- Last Round
- $28.0M Private EquityDec 2000
- Rounds
- 1
About
Developer of innovative bioartificial organ technologies and cell systems for liver, pancreas, and kidney diseases.
Summary
Circe Biomedical is a Biotech company based in United States. It has raised $28.0M in total across 1 round, most recently a $28.0M Private Equity round in Dec 2000. Investors include Polaris Partners and Burrill & Company.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Dec 2000
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...